Literature DB >> 7475881

Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.

H Sudhoff1, J Bujía, A Fisseler-Eckhoff, A Holly, C Schulz-Flake, H Hildmann.   

Abstract

Middle ear cholesteatoma is often invasive with consequent bone destruction. Inflammatory stimulation of the underlying connective tissue, as well as an autocrine mechanism, may be responsible for the dysregulation and abnormal proliferative features of the keratinocytes in cholesteatoma. Comparative investigations were performed to assess the epithelial cell kinetics of cholesteatoma and normal auditory meatal skin. Monoclonal antibody MIB 1 immunostaining (which recognizes a nuclear antigen expressed by dividing cells) was applied using the alkaline phosphatase antialkaline phosphatase immunolabeling method. Specimens of normal auditory meatal skin (n = 7) revealed an average MIB 1 score (quotient of the MIB 1-positive cells and the total number of cells) of 7.6 +/- 2.2%. Cholesteatoma samples (n = 13) showed an average MIB 1 score of 17.4 +/- 8.9% and a heterogeneity of proliferating epithelial areas. Epithelial cones growing toward the underlying stroma exhibited high mitotic activity. Statistically, the results of this study confirm a highly significant increase in the proliferation rate of cholesteatoma keratinocytes, which had an MIB 1 score that was 2.3 times higher than the score for keratinocytes of normal external auditory meatal skin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7475881     DOI: 10.1288/00005537-199511000-00017

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.

Authors:  Tolgahan Çatlı; Yıldırım Bayazıt; Akın Yılmaz; Adnan Menevşe; Ozan Gökdoğan; Nebil Göksu; Suat Özbilen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-06       Impact factor: 2.503

2.  In vivo over-expression of KGF mimic human middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Naotaro Akiyama; Yasuaki Shibata; Haruo Takahashi; Tohru Ikeda; Takehiko Koji
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-20       Impact factor: 2.503

Review 3.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

4.  Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.

Authors:  Tomomi Yamamoto-Fukuda; Mariko Terakado; Yoshitaka Hishikawa; Takehiko Koji; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

5.  Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Authors:  Hans-J Welkoborsky; Roland S Jacob; Mike L Hinni
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-01       Impact factor: 2.503

6.  Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.

Authors:  Mahmood A Hamed; Seiichi Nakata; Kazuya Shiogama; Kenji Suzuki; Ramadan H Sayed; Yoichi Nishimura; Noboru Iwata; Kouhei Sakurai; Badawy S Badawy; Ken-Ichi Inada; Hayato Tsuge; Yutaka Tsutsumi
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-12       Impact factor: 3.372

7.  Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.

Authors:  Matthias Schürmann; Felix Oppel; Senyao Shao; Verena Volland-Thurn; Christian Kaltschmidt; Barbara Kaltschmidt; Lars-Uwe Scholtz; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2021-02-24       Impact factor: 5.712

8.  Evaluation of bcl-2, bax and c-erbB-2 Levels in Chronic Otitis Patients with or without Cholesteatoma.

Authors:  Özgür Işık; Turgut Karlıdağ; Bengü Çobanoğlu Şimşek; Erol Keleş; İrfan Kaygusuz; Şinasi Yalçın; İsrafil Orhan; Emrah Sapmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-06-01

9.  Pathogenesis of sinus cholesteatoma.

Authors:  Holger Sudhoff; Mirko Tos
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-30       Impact factor: 3.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.